Catalyst Wire Dossier Catalyst Wire Dossier

Empagliflozin/linagliptin/metformin combination pill

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Empagliflozin/linagliptin/metformin combination pill, covering 2020-02-21 to 2020-02-21. Get the full timeline:

Most recent: Clinical Trial Update: This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills [Phase 1]

See pricing